Purpose. Emergence of multidrug resistance in Neisseria gonorrhoeae, an STI of public health significance is the biggest challenge to gonorrhoea control. Monitoring for antimicrobial resistance is essential for the early detection of emergent drug resistance patterns.
INTRODUCTION
Gonorrhoea caused by Neisseria gonorrhoeae (NG) a bacterial sexually transmitted infection (STI) remains a major global public health concern, primarily because of the development of resistant organisms. It is important not only for its propensity to cause long term reproductive tract morbidity in men and women but also for increasing the risk of human immunodeficiency virus acquisition [1] . The precise global burden of N. gonorrhoeae is difficult to establish because of the lack of diagnostic capability and reporting systems in many parts of the world. Recent WHO estimates of incidence suggest that approximately 78 million new cases of gonorrhea occur globally each year [2] . The Centers for Disease Control and Prevention (CDC) reported over 350 062 cases in 2014, making it the second most common notifiable infection in the United States [3] . Regular monitoring of antimicrobial susceptibility of N. gonorrhoeae is expected to be a standard practice. However it is not adequately implemented worldwide for various reasons which include invasive specimen collection procedures, the fastidious nature of the organism, a need for specialised culture media and trained personnel [4] . Moreover, as a consequence of emphasis on syndromic management of STIs and the introduction of nucleic acid amplification tests (NAATs); isolation of N. gonorrhoeae for susceptibility testing has reduced, especially in India.
In the absence of a vaccine, the control of gonorrhoea is achieved through effective antimicrobial therapy to treat the infection, reduce transmission and to prevent complications. Many countries including India, advocate syndromic approach for the management of STIs. N. gonorrhoeae has developed resistance to sulphonamides, penicillin, tetracycline, macrolides and fluoroquinolones in many parts of world [5, 6] . According to the WHO, the use of an antimicrobial in empiric treatment is discontinued when the rates of therapeutic failures and/or antimicrobial resistance reach a level of 5 % [7] . Over the past few years, gonococcal resistance to third-generation cephalosporins recommended as first choice of treatment has emerged rapidly in different parts of world. Consequently, the CDC currently recommends dual therapy with ceftriaxone plus azithromycin as treatment for uncomplicated gonorrhea [8] . Though there are no reports of treatment failure with cephalosporins from India, there are reports of treatment failure due to cephalosporins from Japan, Hong Kong, Norway, United Kingdom, France, Norway, Austria and South Africa [6, [9] [10] [11] . In the European, WHO Western Pacific and WHO Southeast Asian regions resistance or decreased susceptibility to ceftriaxone/cefixime was found to be !5 % whereas in Canada, United States and Africa it was found to be 5 % [6] . Furthermore, elevated minimum inhibitory concentrations (MICs) to cephalosporins have been reported from Japan, Australia, China, Hong Kong, USA, various parts of Europe and India [12, 13] .
While there are no universally accepted guidelines for testing antimicrobial susceptibility of N. gonorrhoeae by disc diffusion method, different techniques are practiced, like the Clinical and Laboratory Standards Institute (CLSI) method, the Australian Gonococcal Surveillance Program method and the British Society for Antimicrobial Chemotherapy method. The recommended procedure for antimicrobial susceptibility testing of gonococci is a determination of the MIC by agar dilution or Etest. There have been sparse reports of comparison of these different methods of antimicrobial susceptibility [14] [15] [16] .
Emergence of multidrug resistance (MDR) in N. gonorrhoeae can pose challenges in the control of gonorrhoea. Periodic monitoring of antimicrobial susceptibility of N. gonorrhoeae is essential for the early detection of the emergence of drug resistance for current use of treatment. Therefore, our study was conducted to determine antimicrobial susceptibility of N. gonorrhoeae isolates from five cities in India and to compare the disc diffusion method with Etest for seven antibiotics.
METHODS

Sample collection
Specimens were obtained from men with symptoms of urethritis and women with symptoms of cervical discharge attending sexually transmitted disease clinics between September 2013-August 2016 from different cities (New Delhi, Pune, Mumbai, Hyderabad and Secunderabad) in India.
Isolation and identification of N. gonorrhoeae isolates The specimens were inoculated directly either onto the Modified Thayer Martin medium or on chocolate agar and saponin lysed blood agar with vancomycin, colistin, nystatin, and trimethoprim supplement. The culture plates were incubated in a dessicator (candle jar) or plastic jar at 36 C with 5 % CO 2 and 45 % moisture for 24-72 h. The swabs from Hyderabad and Mumbai were collected in Stuart transport medium and transported to NARI for culture. The colonies suspected to be N. gonorrhoeae were presumptively identified by Gram stain, oxidase and confirmed using superoxal tests, rapid carbohydrate utilisation test and Phadebact monoclonal GC kit (MKL Diagnostics). N. gonorrhoeae isolates were tested for b-Lactamase production by the chromogenic cephalosporin method using nitrocefin discs (Becton, Dickinson and Company). All the N. gonorrhoeae isolates were stored at À70 C in nutrient broth containing 20 % glycerol at NARI [17] .
Antimicrobial susceptibility testing Antimicrobial susceptibility testing for strains isolated from Delhi and Osmania Medical College, Hyderabad were performed at STD Reference laboratory at Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi. The antimicrobial susceptibility testing for strains isolated from Mumbai, Gandhi Medical College (Secunderabad) and Pune were performed at National AIDS Research Institute, Pune. The same methods were used in both settings.
Inoculum preparation
A homogenous suspension of 0.5 McFarland turbidity was prepared from 18 to 24 h old culture growth on GC agar base (Himedia laboratories) with 1 % BBL Isovitalex Enrichment (Becton Dickinson). For both the methods, inoculum was prepared by emulsifying 2-3 colonies in 2.5 ml sterile saline (0.85 %). This suspension was used within 15 mins. All the plates for antimicrobial susceptibility testing were incubated at 36 C for 18-24 h [17] .
CLSI disc diffusion method
Antibiotic susceptibility was performed on GC agar base (Himedia laboratories) with 1 % BBL Isovitalex enrichment (Becton Dickinson) with the following discs (Hi media laboratories, India and Oxoid, UK): penicillin (10IU), tetracycline (30 µg), ciprofloxacin (5 µg), ceftriaxone (30 µg), cefixime (5 µg), spectinomycin (100 µg) and azithromycin (10 µg). The results were interpreted by measuring the inhibition zone diameters and categorised as susceptible (S), intermediate (I) and resistant (R) using CLSI guidelines [18] .
Etest method
The Etest method was used as the reference method. 
Antibiotic susceptibility
The results of the antimicrobial susceptibility testing of all 124 isolates of Neisseria gonorrhoeae by CLSI disc diffusion technique are summarised in Table 1 . Antimicrobial resistance profile by Etest method is shown in Table 2 .
All the strains were susceptible to spectinomycin, ceftriaxone and cefixime except for two strains which showed decreased susceptibility to ceftriaxone and cefixime (MIC=0.25 µg ml Of the total isolates, 51 % were resistant to penicillin (MIC=1-!32 µg ml Table 3 .
There were no major discrepancies identified between CLSI and Etest methods. [20, 21] . A large proportion of the strains in our study were from the New Delhi region followed by Hyderabad-Secunderabad. While the current study depicts emergence of MDR resistance from the southeastern part of India, the paucity of samples from western India (Pune and Mumbai) could be one of the explanations why MDR was not documented in this region. It is likely that extensive use of antibiotics without performing Chromosomally mediated resistance to penicillin Non-PPNG; MIC(penicillin)!2 µg ml
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and <16 µg ml susceptibility testing has generated not only an escalation of 'treatment failures', but also a positive selection pressure for MDR [9, 10] . Syndrome based treatment programs would need to factor in these data moving forward. Studies from United States and Europe have also reported high prevalence of MDR strains (20-55 %) while studies from African and South East Asian Countries have reported low prevalence (1-10 %) probably reflecting antibiotic access in these regions [22] [23] [24] [25] [26] .
Resistance to ciprofloxacin was found to be 98.4 % [CI: 96.2-100] in our study. The prevalence of ciprofloxacinresistant gonococci increased considerably from 67.3 % in 2003 to 99 % in 2014 in India [27, 28] . Studies from South East Asian countries and the WHO Western Pacific Regions report high levels of ciprofloxacin resistance (70-100 %) [29, 30] while resistance to ciprofloxacin (5-60 %) is lower in United States, African and European countries [3, 31, 32] . However, less than 2 % resistance to ciprofloxacin was observed in the WHO Western Pacific region countries (Fiji and New Caledonia) [6] .
Although levels (5 %) [CI: 1.2-8.8 %] of azithromycin resistance were relatively low in our study they are approaching the 5 % cut-off accepted as a public health marker. These resistant strains have only been reported from Delhi both in our study and in the past [33] . However our recent data serve as an alert for the Indian subcontinent and there is a need to monitor clinical resistance to azithromycin based treatment in India. Azithromycin is a frequently used antibiotic in India for many ubiquitous medical conditions by medical practioners particularly due to its ease of administration and cost. Globally United States, Canada, Europe and Japan have reported high levels of azithromycin resistance (20-40 %) [34] [35] [36] . In order that India does not join these countries due care and attention to emerging azithromycin resistance needs to be given along with physician education.
We report 100 % susceptibility to spectinomycin; however resistant strains have been reported from India (New Delhi [3, 43, 44] . It may also be useful to continue to track trends in resistance to penicillin moving forward to watch for a possible reversal in the burden of resistant strains.
Significantly, our study found two isolates with decreased susceptibility to ceftriaxone and cefixime, which currently form the backbone of syndromic management in India. Both of these strains were from New Delhi. Decreased susceptibility has also been previously reported from New Delhi, India (0.2-4.2 %) [29, 33] . Cephalosporins form the mainstay for genital discharge therapy in India and again our data could be an important and early warning signal for emergence of resistance. Low level resistance to ceftriaxone and cefixime has been reported from Europe, United States and in Asia (0.3-1.4 %) while Belgium, Denmark, Greece, Norway, Hong Kong, Japan and Korea have already reported !5 % resistance to cephalosporins [3, 6, 32, 45, 46] .
Our study showed significant agreement between CLSI and Etest method for antibiotic susceptibility testing of penicillin, ciprofloxacin, ceftriaxone, spectinomycin, azithromycin and cefixime, most of which are antibiotics of interest in long term. The need for increased surveillance of N. gonorrhoeae isolates requires an accurate and simple method to determine antimicrobial susceptibilities. Our data support the CLSI method of disc diffusion as an equally useful tool for AMR surveillance, especially in lower middle income countries due to ease of availability, lower cost, feasibility and accuracy.
In spite of many efforts it was a challenge to obtain strains from western region (Pune-Mumbai) as there has been an overall decrease in the presentation of symptomatic cases with frank urethral/cervical discharge in outpatient clinics. Thus, the New Delhi region contributed a majority of the strains in our study, followed by the southeastern region of India. It is likely that our study findings are driven by this unequal distribution and less reflective of the western region of India. In conclusion, while we document a high resistance to ciprofloxacin, penicillin and tetracycline, our study highlights that ceftriaxone and cefixime continue to be useful as an empirical first-line therapy for gonorrhea in India. Cefixime along with azithromycin is recommended by the national programme in syndromic management of gonorrhea. The emergence of resistance to azithromycin and documentation of decreased susceptibility to ceftriaxone and cefixime underscores the importance of maintaining a continued surveillance for antibiotic resistance in N. gonorrhoeae. CLSI test method would be equally useful method for susceptibility test and may be utilised to increase AMR surveillance for N. gonorrhoeae in lower-resource Indian laboratories.
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